USE OF ANTI-VEGF AGENTS IN THE TREATMENT OF ENDOMETRIOSIS

摘要

Disclosed are: a composition for use in the treatment of endometriosis, comprising an agent capable of interfering with the production and/or activity of VEGF, and a physiologically acceptable carrier substance; a composition for the treatment of endometriosis comprising an agent which inhibits the activation and/or recruitment of peritoneal macrophages, and a physiologically acceptable carrier, and methods of making the compositions and their use in the treatment of endometriosis.